CC chemokine receptors (orbeta chemokine receptors) areintegral membrane proteins that specifically bind and respond tocytokines of theCC chemokine family. They represent one subfamily ofchemokine receptors, a large family ofG protein-linked receptors that are known as seven transmembrane (7-TM) proteins since they span the cell membrane seven times. To date, ten true members of the CC chemokine receptor subfamily have been described. These are named CCR1 to CCR10 according to the IUIS/WHO Subcommittee on Chemokine Nomenclature.
CCR6, a receptor forCCL20, is expressed on unactivatedmemory T-cells and somedendritic cells. CCR6 is also expressed on Th17 cells.[14] CCR6 is down-regulated in activated T-cells.[15]
CCR7 is a highly important receptor with a role in trafficking of B and T lymphocytes anddendritic cells to and acrosshigh endothelial venules and positioning those cells correctly in T cell zones of secondarylymphoid organs. Its ligands include the related chemokinesCCL19 andCCL21, (previously called ELC and SLC).[16]
CCR8 is associated with Th2 lymphocytes and is therefore found predominantly in thethymus (in humans) although some expression can be found in the brain,spleen,lymph node, and monocytes at thenucleotide level. The ligands for this receptor areCCL1 andCCL16[17]
CCR9 was previously calledorphan receptor GPR 9-6 and is very highly expressed in thymus (on both immature and mature T-cells) while low in lymph nodes and spleen. CCR9 is also abundant in the gut, with its expression associated with T cells of theintestine. The specific ligand of this receptor isCCL25[18] To note, the chemokine binding protein D6 had previously been named CCR9, but this molecule is ascavenger receptor not a true (signaling) chemokine receptor.
CCR10 is receptor forCCL27 andCCL28 that was originally called orphan receptor GPR2.[8][19][20][21] CCR10 has been implicated in inflammation of the skin, and has been shown to recruitregulatory T cells (Tregs) to mucosal layers.
This molecule was originally designated CCR11 due to its ability to bind several CC chemokines (includingCCL19,CCL21 andCCL25) and its structural similarity to chemokine receptors. However, due to the inability of this molecule (also known asCCRL1 and CCX CKR) to generate a signal following ligand interaction, it has been suggested that it is a scavenger receptor for chemokines and not a bona fide chemokine receptor. Thus CCRL1 should not be called CCR11 under the guidelines of the IUIS/WHO Subcommittee on Chemokine Nomenclature.
^abYoun BS, Zhang SM, Lee EK, Park DH, Broxmeyer HE, Murphy PM, et al. (December 1997). "Molecular cloning of leukotactin-1: a novel human beta-chemokine, a chemoattractant for neutrophils, monocytes, and lymphocytes, and a potent agonist at CC chemokine receptors 1 and 3".Journal of Immunology.159 (11):5201–5.doi:10.4049/jimmunol.159.11.5201.PMID9548457.S2CID20622216.
^abOgilvie P, Bardi G, Clark-Lewis I, Baggiolini M, Uguccioni M (April 2001). "Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5".Blood.97 (7):1920–4.doi:10.1182/blood.v97.7.1920.PMID11264152.
^White JR, Imburgia C, Dul E, Appelbaum E, O'Donnell K, O'Shannessy DJ, et al. (November 1997). "Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils".Journal of Leukocyte Biology.62 (5):667–75.doi:10.1002/jlb.62.5.667.PMID9365122.S2CID12197497.
^Blanpain C, Migeotte I, Lee B, Vakili J, Doranz BJ, Govaerts C, et al. (September 1999). "CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist".Blood.94 (6):1899–905.doi:10.1182/blood.V94.6.1899.PMID10477718.
^Acosta-Rodriguez EV, Rivino L, Geginat J, Jarrossay D, Gattorno M, Lanzavecchia A, et al. (June 2007). "Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells".Nature Immunology.8 (6):639–46.doi:10.1038/ni1467.PMID17486092.S2CID21824460.
"Chemokine Receptors".IUPHAR Database of Receptors and Ion Channels. International Union of Basic and Clinical Pharmacology. Archived fromthe original on 2016-03-03. Retrieved2008-11-25.